These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 16302959)
1. Aspects on human amyloid forms and their fibril polypeptides. Westermark P FEBS J; 2005 Dec; 272(23):5942-9. PubMed ID: 16302959 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool. Gazit E FEBS J; 2005 Dec; 272(23):5971-8. PubMed ID: 16302962 [TBL] [Abstract][Full Text] [Related]
3. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins. Meredith SC Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927 [TBL] [Abstract][Full Text] [Related]
4. Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. Fu X; Korenaga T; Fu L; Xing Y; Guo Z; Matsushita T; Hosokawa M; Naiki H; Baba S; Kawata Y; Ikeda S; Ishihara T; Mori M; Higuchi K FEBS Lett; 2004 Apr; 563(1-3):179-84. PubMed ID: 15063745 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the heterogeneity and specificity of interpolypeptide interactions in amyloid protofibrils by measurement of site-specific fluorescence anisotropy decay kinetics. Jha A; Udgaonkar JB; Krishnamoorthy G J Mol Biol; 2009 Oct; 393(3):735-52. PubMed ID: 19716830 [TBL] [Abstract][Full Text] [Related]
6. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616 [TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis. Westermark GT; Westermark P FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650 [TBL] [Abstract][Full Text] [Related]
8. Protein misfolding, functional amyloid, and human disease. Chiti F; Dobson CM Annu Rev Biochem; 2006; 75():333-66. PubMed ID: 16756495 [TBL] [Abstract][Full Text] [Related]
9. Interpreting the aggregation kinetics of amyloid peptides. Pellarin R; Caflisch A J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587 [TBL] [Abstract][Full Text] [Related]
10. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA-amyloidosis in mice. Ganowiak K; Hultman P; Engström U; Gustavsson A; Westermark P Biochem Biophys Res Commun; 1994 Feb; 199(1):306-12. PubMed ID: 8123028 [TBL] [Abstract][Full Text] [Related]
13. From the polymorphism of amyloid fibrils to their assembly mechanism and cytotoxicity. Kreplak L; Aebi U Adv Protein Chem; 2006; 73():217-33. PubMed ID: 17190615 [TBL] [Abstract][Full Text] [Related]
15. Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology. Marek P; Abedini A; Song B; Kanungo M; Johnson ME; Gupta R; Zaman W; Wong SS; Raleigh DP Biochemistry; 2007 Mar; 46(11):3255-61. PubMed ID: 17311418 [TBL] [Abstract][Full Text] [Related]